Re: Biotech, Pharma, and?
EDIT, ONCE, CRSPR and SGMO Are all clinical stage biotechs working in gene therapy gene editing (they are different). The use different technologies but are similar and are fierce competitors for partnering $s. BIIB and is big Biotech and ABBV and TMO are considered big pharma. I don't know about TEVA or the others. I suspect TEVA is mid stage biotech but not sure if the have approved products or not.
Depending on what stage and market cap they have the trading n these should be traded differently. I like SGMO better because it has the lowest MC and yet (iMO) has the most potential. That why I think it will be 40 in 2018.